Longterm clinical outcomes of omalizumab therapy in severe allergic asthma: Study of efficacy and safety

Development and validation of a questionnaire to measure asthma control

Elizabeth F. Juniper, Paul M. O’Byrne, Gordon Guyatt et al. · European Respiratory Journal · 1999 · 2.5K citations · Full text

Medicine, Internal Medicine, Health Assessment +8

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

William W. Busse, Jonathan Corren, Bobby Q. Lanier et al. · Journal of Allergy and Clinical Immunology · 2001 · 1.3K citations · Full text

Life Sciences, Immunology, Pharmacology +16

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Marc Humbert, Richard Beasley, Jon G. Ayres et al. · Allergy · 2004 · 1.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Exploring the Effects of Omalizumab in Allergic Asthma

Nicola A. Hanania, Sally E. Wenzel, Karin Rosén et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 886 citations

Life Sciences, Immunology, Pharmacotherapy +15

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics

M. Solèr, Jonathan Matz, Robert G. Townley et al. · European Respiratory Journal · 2001 · 826 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17